Analyst Price Targets — MED
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 19, 2026 12:13 pm | — | Stephens | $12.00 | $10.71 | TheFly | Medifast price target lowered to $12 from $15 at Stephens |
| November 5, 2024 12:41 pm | Linda Bolton Weiser | D.A. Davidson | $17.00 | $20.40 | StreetInsider | DA Davidson Upgrades Medifast (MED) to Neutral |
| June 5, 2024 6:07 am | Linda Bolton Weiser | D.A. Davidson | $17.50 | $23.97 | StreetInsider | DA Davidson Downgrades Medifast (MED) to Underperform |
| April 30, 2024 5:00 am | Linda Bolton Weiser | D.A. Davidson | $25.00 | $35.51 | StreetInsider | Medifast (MED) PT Lowered to $25 at DA Davidson |
| June 5, 2023 9:09 am | Stephanie Wissink | Jefferies | $150.00 | $81.22 | Benzinga | Wall Street's Most Accurate Analysts Say Hold These 3 Defensive Stocks With Over 6% Dividend Yields |
| April 6, 2023 8:52 am | Linda Bolton Weiser | D.A. Davidson | $94.00 | $96.39 | Benzinga | Check Out 3 High-Yielding Dividend Stocks In Defensive Sector From Wall Street's Most Accurate Analysts |
Latest News for MED
BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) has announced the launch of the Medifast Metabolic Health Institute, established to advance metabolic health through rigorous research and credible, evidence-based education. The institute brings Medifast's clinical research, scientific expertise, and educational resources under a single body, solidifying the company's position in the metabolic health space. It…
MED's Trilivy launch marks a major metabolic-health shift, backed by a 10-year roadmap and growing GLP-1 market focus.
Medifast (MED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Great Lakes Advisors LLC purchased a new position in shares of Medifast Inc (NYSE: MED) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 51,611 shares of the specialty retailer's stock, valued at approximately $548,000. Great Lakes Advisors LLC owned approximately 0.46% of
MED is reshaping its coach network around Executive Directors as productivity rises despite a sharp decline in active earning coaches.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MED.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.